Bvf Inc Bionomics Limited Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding BNOX
# of Institutions
13Shares Held
1.67MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.23MShares$355,7600.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$91,6400.0% of portfolio
-
Ubs Group Ag34.9KShares$10,1200.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$7,5510.0% of portfolio
-
Lewis Asset Management, LLC Lafayette, CA23KShares$6,6690.01% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $2.18M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...